Skip to main content

Peer Review reports

From: Hypofractionated radiotherapy for refractory or relapsed aggressive B-cell lymphoma in the rituximab era

Original Submission
2 Aug 2023 Submitted Original manuscript
13 Sep 2023 Reviewed Reviewer Report
2 Nov 2023 Reviewed Reviewer Report - Angela Boros
19 Nov 2023 Author responded Author comments - Yong Yang
Resubmission - Version 2
19 Nov 2023 Submitted Manuscript version 2
22 Nov 2023 Author responded Author comments - Yong Yang
Resubmission - Version 3
22 Nov 2023 Submitted Manuscript version 3
29 Nov 2023 Reviewed Reviewer Report
29 Dec 2023 Reviewed Reviewer Report - Angela Boros
Resubmission - Version 4
Submitted Manuscript version 4
Publishing
3 Jan 2024 Editorially accepted
13 Jan 2024 Article published 10.1186/s12885-024-11837-2

You can find further information about peer review here.

Back to article page